Structured evidence table for Resveratrol Cognitive Performance Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Resveratrol Cognitive Performance Meta-Analysis | This review summarizes current evidence on nutritional compounds that target aging-related pathways, focusing on interventions that influence mitochondrial health, cognitive performance, immune function, metabolic regulation, and maintenance of muscle mass in older adults. | 4 | Kurtz JA (2026) | Targeted Supplementation and Nutritional Strategies for Healthy Aging: A Review of Physiological and Molecular Benefits. |
| Resveratrol Cognitive Performance Meta-Analysis | Recent findings Evidence indicates that several targeted nutrients, including protein, probiotics, antioxidants, and emerging mitochondrial-support compounds, may contribute to healthy aging. | 4 | Kurtz JA (2026) | Targeted Supplementation and Nutritional Strategies for Healthy Aging: A Review of Physiological and Molecular Benefits. |
| Resveratrol Cognitive Performance Meta-Analysis | A personalized, evidence-informed supplementation strategy integrated with exercise and balanced nutrition may help optimize physiological function in aging adults. | 4 | Kurtz JA (2026) | Targeted Supplementation and Nutritional Strategies for Healthy Aging: A Review of Physiological and Molecular Benefits. |
| Resveratrol Cognitive Performance Meta-Analysis | Purpose of review Aging is marked by progressive physiological decline driven by chronic inflammation, mitochondrial dysfunction, and impaired metabolic and musculoskeletal resilience. | 4 | Kurtz JA (2026) | Targeted Supplementation and Nutritional Strategies for Healthy Aging: A Review of Physiological and Molecular Benefits. |
| Resveratrol Cognitive Performance Meta-Analysis | 1 2 Neurological ailments, encompassing Alzheimer’s disease (AD), Parkinson’s disease (PD), multiple sclerosis (MS), along with various neurodegenerative and neuroinflammatory conditions, constitute an escalating public health concern globally, primarily attributable to the rising life expectancy and the concomitant increase in age-associated cognitive deterioration. | 4 | Wang Haoyu (2026) | Resveratrol and the neuroinflammation axis in Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and cerebral ischemia |
| Resveratrol Cognitive Performance Meta-Analysis | As a result, there is a burgeoning interest in naturally occurring bioactive substances endowed with neuroprotective, anti-inflammatory, and antioxidant characteristics that possess the potential to modulate the molecular pathways that underlie neurodegeneration and cognitive dysfunction. | 4 | Wang Haoyu (2026) | Resveratrol and the neuroinflammation axis in Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and cerebral ischemia |
| Resveratrol Cognitive Performance Meta-Analysis | Beyond its anti-inflammatory and immunomodulatory properties, RES significantly influences molecular pathways associated with memory. | 4 | Wang Haoyu (2026) | Resveratrol and the neuroinflammation axis in Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and cerebral ischemia |
| Resveratrol Cognitive Performance Meta-Analysis | These conditions are distinguished by the progressive degeneration of neurons, neuroinflammatory processes, oxidative stress, mitochondrial dysfunction, and perturbations in immune signaling, culminating in deficits in memory, learning capabilities, and other cognitive functions (,). | 4 | Wang Haoyu (2026) | Resveratrol and the neuroinflammation axis in Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and cerebral ischemia |
Source documents